| 000 | 01228 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516142037.0 | ||
| 264 | 0 | _c20131216 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1744-7682 | ||
| 024 | 7 |
_a10.1517/14712598.2013.767329 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlotz, Luisa | |
| 245 | 0 | 0 |
_aMonoclonal antibodies in neuroinflammatory diseases. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _cJun 2013 |
||
| 300 |
_a831-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aMyasthenia Gravis _xdrug therapy |
| 650 | 0 | 4 |
_aMyositis _xdrug therapy |
| 650 | 0 | 4 |
_aNervous System Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aNeuromyelitis Optica _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWiendl, Heinz | |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 13 _gno. 6 _gp. 831-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.2013.767329 _zAvailable from publisher's website |
| 999 |
_c22607016 _d22607016 |
||